Peter C. Grayson

Research interests

Publications

• Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population

  JAMA · 2023 · https://doi.org/10.1001/jama.2022.24836

• 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis With Polyangiitis

  Arthritis & Rheumatology · 2022 · https://doi.org/10.1002/art.41982

• Large-vessel vasculitis

  Nature Reviews Disease Primers · 2022 · https://doi.org/10.1038/s41572-021-00327-5

• 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis

  Annals of the Rheumatic Diseases · 2022 · https://doi.org/10.1136/annrheumdis-2021-221794

• 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis

  Annals of the Rheumatic Diseases · 2022 · https://doi.org/10.1136/annrheumdis-2021-221795

• 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis

  Annals of the Rheumatic Diseases · 2022 · https://doi.org/10.1136/ard-2022-223480

• 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis

  Annals of the Rheumatic Diseases · 2022 · https://doi.org/10.1136/annrheumdis-2021-221796

• 2022 American College of Rheumatology/EULAR Classification Criteria for Giant Cell Arteritis

  Arthritis & Rheumatology · 2022 · https://doi.org/10.1002/art.42325

• 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Microscopic Polyangiitis

  Arthritis & Rheumatology · 2022 · https://doi.org/10.1002/art.41983

• 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Granulomatosis With Polyangiitis

  Arthritis & Rheumatology · 2022 · https://doi.org/10.1002/art.41986

• Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study

  Blood · 2022 · https://doi.org/10.1182/blood.2022016642

• 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis

  Annals of the Rheumatic Diseases · 2022 · https://doi.org/10.1136/ard-2022-223482

• Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1

  Blood Advances · 2021 · https://doi.org/10.1182/bloodadvances.2021004976

• 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

  Arthritis & Rheumatology · 2021 · https://doi.org/10.1002/art.41773

• 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis

  Arthritis & Rheumatology · 2021 · https://doi.org/10.1002/art.41774

• 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

  Arthritis Care & Research · 2021 · https://doi.org/10.1002/acr.24634

• Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS

  Arthritis & Rheumatology · 2021 · https://doi.org/10.1002/art.41743

• Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease

  New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmoa2026834

• 18 F‐Fluorodeoxyglucose–Positron Emission Tomography As an Imaging Biomarker in a Prospective, Longitudinal Cohort of Patients With Large Vessel Vasculitis

  Arthritis & Rheumatology · 2017 · https://doi.org/10.1002/art.40379

• At the Bench: Neutrophil extracellular traps (NETs) highlight novel aspects of innate immune system involvement in autoimmune diseases

  Journal of Leukocyte Biology · 2015 · https://doi.org/10.1189/jlb.5bt0615-247r

• Distribution of arterial lesions in Takayasu's arteritis and giant cell arteritis

  Annals of the Rheumatic Diseases · 2012 · https://doi.org/10.1136/annrheumdis-2011-200795

• Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis--a meta-analysis

  Lara D. Veeken · 2011 · https://doi.org/10.1093/rheumatology/ker280

• Hyperuricemia and incident hypertension: A systematic review and meta‐analysis

  Arthritis Care & Research · 2010 · https://doi.org/10.1002/acr.20344

• Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia

  Journal of Clinical Investigation · 2001 · https://doi.org/10.1172/jci11537

• Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia

  Journal of Clinical Investigation · 2001 · https://doi.org/10.1172/jci200111537

Current projects

No projects listed.